Cargando…
The expression of VISTA on CD4(+) T cells is associated with poor prognosis and immune status in non-small cell lung cancer patients
V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel negative immune checkpoint considered to be relevant to immunotherapy resistance and a potential target for immunotherapy. In this study, we investigated the relevance of VISTA expression on CD4(+) T cells and clinical progno...
Autores principales: | Ma, Shengyao, Qin, Liya, Wang, Xinling, Wang, Weiyu, Li, Jinfeng, Wang, Huaijie, Li, Hanyue, Cai, Xiaoshan, Yang, Yang, Qu, Meihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519165/ https://www.ncbi.nlm.nih.gov/pubmed/35122478 http://dx.doi.org/10.17305/bjbms.2021.6531 |
Ejemplares similares
-
XPC Protein Improves Lung Adenocarcinoma Prognosis by Inhibiting Lung Cancer Cell Stemness
por: Wang, Weiyu, et al.
Publicado: (2021) -
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
por: Jlassi, Aida, et al.
Publicado: (2023) -
VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021) -
Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer
por: Yang, Jihua, et al.
Publicado: (2018) -
VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)